These findings suggest that post-PCI PTX3 may be a more reliable and independent inflammatory predictor for early risk stratification compared to hsCRP in patients with stable CAD after DES implantation, and measuring PTX3 may substantially improve the early risk stratification of patients after DES implantation. The gene discussed is PTX3; the disease is coronary artery disorder.